Friday, October 28, 2016: 10:30 AM-12:00 PM
Room: La Nouvelle Orleans Ballroom
Learning Objectives:
At the conclusion of this session, participants will be able to:
- describe the impact of respiratory syncytial virus infection in older adults
- define the factors leading the increase in invasive group B streptococcal disease in non-pregnant adults
- cite data supporting the type and duration of antimicrobials for early Lyme disease
Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Researchers, Scientists
Tracks: Adult ID, Epidemiology and Infection Control, Pediatric ID
Moderators:
Samuel Shelburne, MD, PhD, FIDSA, The University of Texas MD Anderson Cancer Center
and
Carol J. Baker, MD, FIDSA, FSHEA, FPIDS, Texas Children’s Hospital, Baylor College of Medicine
Presentations:
CME Credits: Maximum of 1.5 hours of
AMA PRA Category 1 Credit™
ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE
ACPE Number: 0221-9999-16-260-L01-P
Disclosures:
S. Shelburne,
None
C. J. Baker,
Pfizer, Inc.:
Consultant
,
Consulting fee
CureVac, Inc.:
Consultant
,
Consulting fee
Seqirus, Inc.:
Consultant
,
Consulting fee